Even closer to the production of cancer vaccines is the scientific community, according to what Ugur Sahin said, leading scientist of Turkish origin and one of the founders of BioNTech, created the Pfizer vaccine against coronavirus.
"We have started trials in hundreds of patients and we will have results next year, and 2023. If these tests are positive, then could pave the way for two, three, four years to approve the first cancer vaccines», said Ogur Sahin in Kathimerini, explaining how the lives of cancer patients will change.
"After the operations, in many volumes, about the 30%-40% of patients recur within two or three years. And this is one of the main problems in cancer. What we want to achieve with cancer vaccines is to prevent relapses in cancer patients.».
In addition, Sahin also spoke about mRNA vaccines: "We actually started working on mRNA technology in the late '90s, and from 2012 we started treating cancer patients with mRNA vaccine. Vaccines have nothing to do with prevention as in the case of a virus.
Patients already have large partial cancer tumors and the vaccine must be very strong to activate the immune system accurately, but also drastically to shrink these tumors. So we invested a lot in making a very powerful vaccine to stimulate high-precision immune responses. ".
End, was also placed for DNA change scenarios: "It does a job and triggers an immune response and disappears within two days to two weeks. So, there is nothing that changes anything in the body».
Source: Newsbeast.gr
